CALIMMUNE INC has a total of 55 patent applications. It decreased the IP activity by 23.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are GENETIC THERAPY INC, LINEAGE CELL THERAPEUTICS INC and QYH BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | United States | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 9 | |
#4 | Canada | 8 | |
#5 | China | 7 | |
#6 | Japan | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Hong Kong | 2 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Animal care | |
#7 | Analysing materials | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Bartlett Jeffrey S | 23 |
#2 | Symonds Geoffrey Phillip | 23 |
#3 | Breton Louis Randall | 20 |
#4 | Suzuki Kazuo | 12 |
#5 | Kelleher Anthony Dominic | 12 |
#6 | Bartlett Jeffrey | 11 |
#7 | Lee Chi-Lin | 11 |
#8 | Yan Ming | 11 |
#9 | Chen Irvin | 9 |
#10 | An Dong Sung | 9 |
Publication | Filing date | Title |
---|---|---|
SG11202000428PA | A modulatable switch for selection of donor modified cells | |
CA3070242A1 | Compositions and methods for treating beta-hemoglobinopathies | |
US2018140606A1 | In Vivo Chemoselection with Low Dose Thioguanine | |
WO2018035457A1 | Methods and compositions for treating canine conditions using recombinant self-complementary adeno-associated virus | |
WO2018035451A1 | Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus | |
WO2016187151A1 | Methods of discriminating between hiv-1 and lentiviral vectors | |
CN107660231A | The biological production of slow virus carrier | |
WO2016186708A1 | Gene therapeutic for the treatment of hiv and uses thereof | |
EP2949208A1 | Dual vector for inhibition of human immunodeficiency virus |